Prevarex

Prevarex is a biotechnology company dedicated to developing universal vaccines and therapeutics for infectious diseases. Utilizing a proprietary platform, the company identifies and targets highly conserved, mutation-resistant epitopes on viral surfaces to provide broad-spectrum protection against evolving pathogens. Their current pipeline includes programs for a universal COVID-19 vaccine and a broad-spectrum influenza vaccine designed to overcome the limitations of traditional seasonal reformulations. By focusing on viral regions that remain stable across different strains and variants, Prevarex aims to eliminate the need for frequent vaccine updates and provide long-lasting immunity.